Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Duha M. Al-Shorafat"'
Autor:
Leonie F. Becker, Sinem Tunc, Peter Murphy, Tobias Bäumer, Anne Weissbach, Martje G. Pauly, Duha M. Al-Shorafat, Gerard Saranza, Anthony E. Lang, Christian Beste, Tobias H. Donner, Julius Verrel, Alexander Münchau
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Dopa-responsive dystonia (DRD) is caused by an impaired dopamine biosynthesis due to a GTP-cyclohydrolase-1 (GCH1) deficiency, resulting in a combination of dystonia and parkinsonism. However, the effect of GCH1 mutations and levodopa treatm
Externí odkaz:
https://doaj.org/article/06c8a7b3c4a44af0832037c6d5c69403
Autor:
Anne Weissbach, Annika Steinmeier, Martje Pauly, Duha M. Al-Shorafat, Gerard Saranza, Anthony Lang, Norbert Brüggemann, Vera Tadic, Christine Klein, Alexander Münchau, Tobias Bäumer, Matt J.N. Brown
Publikováno v:
Parkinsonism & Related Disorders. 95:40-46
GCH1 mutations have been linked to decreased striatal dopamine and development of dopa-responsive dystonia (DRD) and Parkinsonism. Sensory and sensorimotor integration impairments have been documented in various forms of dystonia. DRD patients with c
Publikováno v:
Journal of Blood Medicine.
Mahmoud H Ayesh Haj Yousef,1 Ziad Audat,2 Duha M Al-Shorafat,3 Sohaib Al-Khatib,4 Ammar K Daoud1 1Department of Internal Medicine, Faculty of Medicine, King Abdullah University Hospital, Jordan University of Science and Technology, Irbid, Jordan; 2De
Autor:
Leonie F. Becker, Sinem Tunc, Peter Murphy, Tobias Bäumer, Anne Weissbach, Martje G. Pauly, Duha M. Al-Shorafat, Gerard Saranza, Anthony E. Lang, Christian Beste, Tobias H. Donner, Julius Verrel, Alexander Münchau
Publikováno v:
Scientific reports. 12(1)
Dopa-responsive dystonia (DRD) is caused by an impaired dopamine biosynthesis due to a GTP-cyclohydrolase-1 (GCH1) deficiency, resulting in a combination of dystonia and parkinsonism. However, the effect of GCH1 mutations and levodopa treatment on mo
Publikováno v:
Neurodegenerative Disease Management. 9:135-147
Treatment strategies for dystonia depend on the focal, segmental or generalized distribution of symptoms. Chemodenervation with botulinum toxin remains the treatment of choice for focal- or select-body regions in generalized and segmental dystonia. A
Publikováno v:
Mov Disord Clin Pract
Background Although the β-blocker propranolol is considered one of the most effective tremor treatments and other β-blockers are often prescribed to patients with tremor, those with partial β-agonist activity on β-adrenoreceptors can theoreticall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9797d3d75af4971d54341680617c436
https://europepmc.org/articles/PMC8015902/
https://europepmc.org/articles/PMC8015902/
Autor:
Becker, Leonie F.1 (AUTHOR), Tunc, Sinem1,2 (AUTHOR), Murphy, Peter3,4,5 (AUTHOR), Bäumer, Tobias1 (AUTHOR), Weissbach, Anne1,6 (AUTHOR), Pauly, Martje G.1,2,6 (AUTHOR), Al-Shorafat, Duha M.7,8 (AUTHOR), Saranza, Gerard7,9 (AUTHOR), Lang, Anthony E.7 (AUTHOR), Beste, Christian10 (AUTHOR), Donner, Tobias H.3 (AUTHOR), Verrel, Julius1 (AUTHOR), Münchau, Alexander1 (AUTHOR) alexander.muenchau@neuro.uni-luebeck.de
Publikováno v:
Scientific Reports. 8/22/2022, Vol. 12 Issue 1, p1-10. 10p.
Autor:
Yousef, Mahmoud H Ayesh Haj (AUTHOR), Audat, Ziad (AUTHOR), Al-Shorafat, Duha M (AUTHOR), Al-Khatib, Sohaib (AUTHOR), Daoud, Ammar K (AUTHOR)
Publikováno v:
Journal of Blood Medicine. Mar2022, Vol. 13, p143-149. 7p.
Autor:
Al‐Shorafat, Duha M.1 (AUTHOR), Bhowmick, Suvorit1 (AUTHOR), Espay, Alberto J.2 (AUTHOR), Fasano, Alfonso1,3 (AUTHOR) alfonso.fasano@uhn.ca
Publikováno v:
Movement Disorders Clinical Practice. Apr2021, Vol. 8 Issue 3, p449-452. 4p.
Publikováno v:
Movement Disorders Clinical Practice. Apr2021, Vol. 8 Issue 3, p293-298. 6p.